US Patent Litigations are now available. Check here

EP2585075

MERITAGE PHARMA
Application Number
EP11799004A
Filing Date
Jun 24, 2011
Status
Revoked
Dec 9, 2022
Grant Date
Sep 22, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2585075B8 was granted on Sep 22, 2021 by Meritage Pharma The patent is currently Revoked.

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionEP2585075B8
N/A
OppositionUS2007111978
N/A
OppositionUS2009123550
N/A
OppositionUS2009181099
N/A
OppositionWO2009132048
N/A
OppositionWO2011163614
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.